Target Healthcare REIT (LON:THRL) Sets New 52-Week High – Should You Buy?

Target Healthcare REIT (LON:THRL) reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 95 ($1.23) and last traded at GBX 91.80 ($1.19), with a volume of 3152406 shares changing hands. The stock had previously closed at GBX 92.80 ($1.20).

Target Healthcare REIT Stock Up 1.3 %

The company has a debt-to-equity ratio of 34.92, a quick ratio of 1.52 and a current ratio of 7.20. The stock has a market cap of £575.37 million, a P/E ratio of 7.88, a P/E/G ratio of 1.48 and a beta of 0.44. The stock’s fifty day simple moving average is GBX 84.53 and its 200-day simple moving average is GBX 85.90.

Target Healthcare REIT (LON:THRL) last issued its quarterly earnings results on Friday, March 14th. The company reported GBX 3.06 ($0.04) earnings per share for the quarter. Target Healthcare REIT had a net margin of 104.99% and a return on equity of 10.78%. As a group, research analysts forecast that Target Healthcare REIT will post 6.2219101 earnings per share for the current fiscal year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.